1
|
Wenz F, Sperk E, Budach W, Dunst J, Feyer
P, Fietkau R, Haase W, Harms W, Piroth MD, SautterBihl ML, et al:
Breast Cancer Expert Panel of the German Society of Radiation
Oncology (DEGRO): DEGRO practical guidelines for radiotherapy of
breast cancer IV: Radiotherapy following mastectomy for invasive
breast cancer. Strahlenther Onkol. 190:705–714. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Dewis R and Gribbin J: Breast Cancer:
Diagnosis and treatment. An assessment of needNational Institute
for Health and Clinical Excellence clinical guidelines. National
Collaborating Centre for Cancer; Cardiff (UK): February. 2009
|
3
|
EBCTCG (Early Breast Cancer Trialists'
Collaborative Group). McGale P, Taylor C, Correa C, Cutter D, Duane
F, Ewertz M, Gray R, Mannu G, Peto R, et al: Effect of radiotherapy
after mastectomy and axillary surgery on 10-year recurrence and
20-year breast cancer mortality: Meta-analysis of individual
patient data for 8135 women in 22 randomised trials. Lancet.
383:2127–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nordenskjöld AE, Fohlin H, Albertsson P,
Arnesson LG, Chamalidou C, Einbeigi Z, Holmberg E, Nordenskjöld B
and Karlsson P: Swedish Western and Southeastern Breast Cancer
Groups: No clear effect of postoperative radiotherapy on survival
of breast cancer patients with one to three positive nodes: A
population-based study. Ann Oncol. 26:1149–1154. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kong M and Hong SE: Which patients might
benefit from postmastectomy radiotherapy in breast cancer patients
with t1-2 tumor and 1-3 axillary lymph nodes metastasis? Cancer Res
Treat. 45:103–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chitapanarux I, Tharavichitkul E,
Jakrabhandu S, Klunklin P, Onchan W, Srikawin J, Pukanhaphan N,
Traisathit P and Vongtama R: Real-world outcomes of postmastectomy
radiotherapy in breast cancer patients with 1-3 positive lymph
nodes: A retrospective study. J Radiat Res. 55:121–128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Cosar R, Uzal C, Tokatli F, Denizli B,
Saynak M, Turan N, Uzunoglu S, Ozen A, Sezer A, Ibis K, et al:
Postmastectomy irradiation in breast in breast cancer patients with
T1-2 and 1-3 positive axillary lymph nodes: Is there a role for
radiation therapy? Radiat Oncol. 6:282011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wu SG, He ZY, Li FY, Wang JJ, Guo J, Lin Q
and Guan XX: The clinical value of adjuvant radiotherapy in
patients with early stage breast cancer with 1 to 3 positive lymph
nodes after mastectomy. Chin J Cancer. 29:668–676. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ragaz J, Jackson SM, Le N, Plenderleith
IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM,
Paradis M, et al: Adjuvant radiotherapy and chemotherapy in
node-positive premenopausal women with breast cancer. N Engl J Med.
337:956–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
10
|
Su YL, Li SH, Chen YY, Chen HC, Tang Y,
Huang CH, Chou FF, Wu SC and Rau KM: Post-mastectomy radiotherapy
benefits subgroups of breast cancer patients with T1-2 tumor and
1-3 axillary lymph node(s) metastasis. Radiol Oncol. 48:314–322.
2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Moo TA, McMillan R, Lee M, Stempel M,
Patil S, Ho A and El-Tamer M: Selection criteria for postmastectomy
radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann
Surg Oncol. 20:3169–3174. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Huang CJ, Hou MF, Chuang HY, Lian SL,
Huang MY, Chen FM, Fu OY and Lin SF: Comparison of clinical outcome
of breast cancer patients with T1-2 tumor and one to three positive
nodes with or without postmastectomy radiation therapy. Jpn J Clin
Oncol. 42:711–720. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
He ZY, Wu SG, Zhou J, Li FY, Lin Q, Lin HX
and Sun JY: Postmastectomy radiotherapy improves disease-free
survival of high risk of locoregional recurrence breast cancer
patients with T1-2 and 1 to 3 positive nodes. PLoS One.
10:e01191052015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tendulkar RD, Rehman S, Shukla ME, Reddy
CA, Moore H, Budd GT, Dietz J, Crowe JP and Macklis R: Impact of
postmastectomy radiation on locoregional recurrence in breast
cancer patients with 1-3 positive lymph nodes treated with modern
systemic therapy. Int J Radiat Oncol Biol Phys. 83:e577–e581. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
McBride A, Allen P, Woodward W, Kim M,
Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, et al:
Locoregional recurrence risk for patients with T1,2 breast cancer
with 1-3 positive lymph nodes treated with mastectomy and systemic
treatment. Int J Radiat Oncol Biol Phys. 89:392–398. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Harris EE, Freilich J, Lin HY, Chuong M
and Acs G: The impact of the size of nodal metastases on recurrence
risk in breast cancer patients with 1-3 positive axillary nodes
after mastectomy. Int J Radiat Oncol Biol Phys. 85:609–614. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Overgaard M, Hansen PS, Overgaard J, Rose
C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen
MB and Zedeler K: Postoperative radiotherapy in high-risk
premenopausal women with breast cancer who receive adjuvant
chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N
Engl J Med. 337:949–955. 1997. View Article : Google Scholar : PubMed/NCBI
|
18
|
Khan M, Gupta M and Seam R: Analysis of
cardiac adverse events following postmastectomy hypofractionated
radiotherapy. Chin Clin Oncol. 3:472014.PubMed/NCBI
|
19
|
Kunkler IH: Radiotherapy of the regional
lymph nodes: Shooting at the sheriff? Breast. 18(Suppl 3):
S112–S120. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Harris EE: Cardiac mortality and morbidity
after breast cancer treatment. Cancer Control. 15:120–129.
2008.PubMed/NCBI
|
21
|
Doyle JJ, Neugut AI, Jacobson JS, Wang J,
McBride R, Grann A, Grann VR and Hershman D: Radiation therapy,
cardiac risk factors and cardiac toxicity in early-stage breast
cancer patients. Int J Radiat Oncol Biol Phys. 68:82–93. 2007.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Berbers J, van Baardwijk A, Houben R,
Heuts E, Smidt M, Keymeulen K, Bessems M, Tuinder S and Boersma LJ:
‘Reconstruction: Before or after postmastectomy radiotherapy?’ A
systematic review of the literature. Eur J Cancer. 50:2752–2762.
2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mitchell RE: Porcine acellular
dermis-assisted breast reconstruction: Influence of adjuvant
radiotherapy on complications and outcomes. Plast Reconstr Surg
Glob Open. 1:e772013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rochlin DH, Jeong AR, Goldberg L, Harris
T, Mohan K, Seal S, Canner J and Sacks JM: Postmastectomy radiation
therapy and immediate autologous breast reconstruction: Integrating
perspectives from surgical oncology, radiation oncology, and
plastic and reconstructive surgery. J Surg Oncol. 111:251–257.
2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kunkler IH, Canney P, van Tienhoven G and
Russell NS: MRC/EORTC (BIG 2-04) SUPREMO Trial Management Group:
Elucidating the role of chest wall irradiation in
‘intermediate-risk’ breast cancer: The MRC/EORTC SUPREMO trial.
Clin Oncol (R Coll Radiol). 20:31–34. 2008. View Article : Google Scholar : PubMed/NCBI
|